Headlines of narcolepsy related news
Friday, December 21, 2018 – Jazz Pharma gets new PDUFA date for drug for excessive sleepiness solriamfetol/JZP-110. Read more about this article here.
Thursay, November 29, 2018 – Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia. Read more about this article here.
Friday, November 9, 2018 – Jazz Pharmaceuticals has filed a marketing application in Europe seeking approval for solriamfetol/JZP-110, a selective dopamine and norepinephrine reuptake inhibitor, to improve wakefulness and reduce excessive daytime sleepiness in adult patients with narcolepsy (with or without cataplexy) or obstructive sleep apnea.. Read more about this article here.
Thursday, March 22, 2018 – NAXION, a market research company, is conducting interviews with people diagnosed with narcolepsy. Read more about this research here.
Friday, March 16, 2018 – Sleeping for Longer Leads to Healthier Diet, Finds Randomized Controlled Trial – by Sleep Review Magazine
Thursday, December 21, 2017 – Screen Time Before Bed Linked with Less Sleep, Higher BMIs in Kids – by Sleep Review Magazine
Thursday, December 21, 2017 – Wake Up Narcolepsy Brings on Claire Crisp as Executive Director – by Sleep Review Magazine
Saturday, October 21, 2017 – JZP-110 Shows Efficacy in Treating Function and Work Productivity Impairment in Patients with OSA by Sleep Review Magazine
Saturday, October 21, 2017 – The Top 5 Stress-Causing Foods You Should Avoid by Dr. Josh Axe
Sunday, October 8, 2017 – Harmony Biosciences Acquires US Rights to Pitolisant From Bioprojet; Raises $270 Million in Equity Financing
Saturday, September 30, 2017 – Wake-promoting compound validated ― the first step to deliver a magic bullet for curing narcolepsy, from University of Tsukuba.
Saturday, September 16, 2017 – Listing of narcolepsy related events for PWN in the UK.
Wednesday, August 9, 2017 – All participating clinics known now in USA for Avadel one dose oxybate Trials.
Tuesday, August 8, 2017 – From the American Association of Sleep Technologists: Do I Have Narcolepsy? How Polysomnography and MSLT Help Us To Understand
Wednesday, May 24, 2017 – Prescription drug prices rose nearly 10% in 2016 in USA.
Wednesday, April 5, 2017 – Flamel/Avadel starts Trials with “one dose” Oxybate product in USA and Netherlands.
Monday, March 20, 2017 – 2018 European Narcolepsy Day of EUNN will be in Montpellier, France.
Thursday, March 16, 2017 – JZP-258 of Jazz Pharmaceuticals enrolls 1st patient in Phase 3 clinical study.
Thursday, March 2, 2017 – New research suggests Pitolisant to reduce cataplexy in patients with narcolepsy.
Wednesday, Januari 18, 2017 – World Sleep Society announces World Sleep Congres for October in Prague.
Tuesday, Januari 17, 2017 – FDA approves generic version of Jazz Pharma’s Xyrem.
Tuesday, Januari 17, 2017 – Flamel/Avadel starts Trials with “one dose” Oxybate product in France and Germany
Thursday, November 3, 2016 – PWN4PWN opens new, mobile ready, website
Monday, October 24, 2016 – PWN4PWN opens narcolepsy register at CoRDS
Saturday, October 22, 2016 – Flamel Technologies Announces Start of human Trial with Micropump® Sodium Oxybate.
Monday, July 11, 2016 – Mazindol granted orphan drug designation in the US & Europe for treating narcolepsy.
Monday, March 14, 2016 – Baclofen gaining popularity by more and more users reporting being successful.
Thursday, February 25, 2016 – Pitolisant approved for Europe.
Friday, November 27, 2015 – Flamel Technologies announces sachets for their new Oxybate product. See our facebook page.
